Memories.ai | $8,000,000 | (Jul 25, 2025)
Lyra (YC X25) | $6,000,000 | (Jul 25, 2025)
Maro | $4,300,000 | (Jul 25, 2025)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
STELLARIA 🌀 | $23,000,000 | (Jul 25, 2025)
LegalOn Technologies | $50,000,000 | (Jul 25, 2025)
Bloom | $1,600,000 | (Jul 25, 2025)
Baxter Aerospace | $6,000,000 | (Jul 25, 2025)
Flend | $3,000,000 | (Jul 25, 2025)
Cascade Space | $5,900,000 | (Jul 25, 2025)
Scopio Labs | $10,000,000 | (Jul 25, 2025)
ArcSpan | $5,200,000 | (Jul 24, 2025)